[go: up one dir, main page]

DK2448968T3 - ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER - Google Patents

ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER Download PDF

Info

Publication number
DK2448968T3
DK2448968T3 DK10739701.0T DK10739701T DK2448968T3 DK 2448968 T3 DK2448968 T3 DK 2448968T3 DK 10739701 T DK10739701 T DK 10739701T DK 2448968 T3 DK2448968 T3 DK 2448968T3
Authority
DK
Denmark
Prior art keywords
protofibrills
trunked
amyloid
oligomers
terminal
Prior art date
Application number
DK10739701.0T
Other languages
English (en)
Inventor
Pär GELLERFORS
Lars Lannfelt
Linda Söderberg
Karin Tegerstedt
Original Assignee
Bioarctic Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioarctic Ab filed Critical Bioarctic Ab
Application granted granted Critical
Publication of DK2448968T3 publication Critical patent/DK2448968T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK10739701.0T 2009-06-29 2010-06-29 ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER DK2448968T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22110509P 2009-06-29 2009-06-29
PCT/IB2010/052947 WO2011001366A1 (en) 2009-06-29 2010-06-29 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease

Publications (1)

Publication Number Publication Date
DK2448968T3 true DK2448968T3 (da) 2021-04-12

Family

ID=42832352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10739701.0T DK2448968T3 (da) 2009-06-29 2010-06-29 ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER

Country Status (16)

Country Link
US (2) US20120100129A1 (da)
EP (2) EP3892633A1 (da)
JP (3) JP2012532094A (da)
AU (1) AU2010267640B2 (da)
CA (1) CA2765602C (da)
CY (1) CY1124034T1 (da)
DK (1) DK2448968T3 (da)
ES (1) ES2864049T3 (da)
HR (1) HRP20210611T1 (da)
HU (1) HUE053949T2 (da)
LT (1) LT2448968T (da)
PL (1) PL2448968T3 (da)
PT (1) PT2448968T (da)
SI (1) SI2448968T1 (da)
SM (1) SMT202100237T1 (da)
WO (1) WO2011001366A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401601D0 (sv) 2004-06-21 2004-06-21 Bioarctic Neuroscience Ab Protofibril specific antibodies and uses thereof
ATE492561T1 (de) 2006-03-23 2011-01-15 Bioartic Neuroscience Ab Verbesserte protofibrilselektive antikörper und deren verwendung
HUE038313T2 (hu) 2010-02-26 2018-10-29 Bioarctic Neuroscience Ab Protofibril-kötõ antitestek és alkalmazásuk Parkinson-kór, Lewy-testes demencia és más alfa-szinukleinopátiák terápiás és diagnosztikai eljárásaiban
SG192805A1 (en) 2011-03-16 2013-09-30 Probiodrug Ag Diagnostic antibody assay
HRP20210680T1 (hr) 2014-07-10 2021-06-11 Bioarctic Ab POBOLJŠANA PROTUTIJELA KOJA VEŽU Aβ PROTOFIBRIL
CN107849125A (zh) 2015-07-21 2018-03-27 生命北极神经科学公司 用于治疗靶向聚集的肽的创伤性脑损伤的方法
MA45684A (fr) 2016-07-14 2019-05-22 Bioarctic Neuroscience Ab Protéine d'apport du cerveau
WO2019023247A1 (en) 2017-07-25 2019-01-31 Immutics, Inc. TREATMENT OF CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
CA3107370A1 (en) 2018-07-24 2020-01-30 Eisai R&D Management Co., Ltd. Methods of treatment and prevention of alzheimer's disease
JP2022523333A (ja) 2019-01-30 2022-04-22 トゥルーバインディング,インコーポレイテッド 抗gal3抗体およびその使用
US20220251518A1 (en) * 2019-07-08 2022-08-11 Terumo Kabushik Kaisha Hybridoma, method for making the same, monoclonal antibody, and method for making the same
WO2021055670A1 (en) 2019-09-20 2021-03-25 Avx Corporation Somatic cell-based electrical biosensor
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
MX2022016005A (es) 2020-06-26 2023-02-02 Bioarctic Ab Anticuerpos de fijacion a protofibrillas de \03b1-sinucleina.
US20250163135A1 (en) 2021-07-09 2025-05-22 Eisai R&D Management Co., Ltd. Biomarkers for alzheimer's disease treatment
KR20240053620A (ko) 2021-08-30 2024-04-24 에자이 알앤드디 매니지먼트 가부시키가이샤 항-a베타 프로토피브릴 항체의 피하 제형 및 이를 사용하는 방법
KR20240142535A (ko) 2022-02-02 2024-09-30 에자이 알앤드디 매니지먼트 가부시키가이샤 P-tau181 수준을 사용한 치료 방법
TW202440628A (zh) 2022-12-22 2024-10-16 瑞典商生物極公司 新抗體
WO2025262228A1 (en) 2024-06-20 2025-12-26 Bioarctic Ab Bispecific binding molecule

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604102A (en) 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
AU6524500A (en) * 1999-08-04 2001-03-05 Northwestern University Amyloid beta protein (globular assembly and uses thereof)
EP2082749A3 (en) 2000-07-07 2010-06-30 Bioarctic Neuroscience AB Prevention and treatment of Alzheimer's disease
US7122374B1 (en) * 2002-04-09 2006-10-17 Takaomi Saido Amyloid beta-protein 3(pE)-42 antibodies and uses thereof
AU2003250102B2 (en) * 2002-07-24 2009-09-17 Innogenetics N.V. Fragments of beta-amyloid as targets for vaccination against alzheimer disease
EP2374817B1 (en) * 2004-04-13 2017-09-06 F. Hoffmann-La Roche AG Anti-P-selectin antibodies
GB0413726D0 (en) * 2004-06-18 2004-07-21 Lauras As Compounds
SE0401601D0 (sv) * 2004-06-21 2004-06-21 Bioarctic Neuroscience Ab Protofibril specific antibodies and uses thereof
MX2007000998A (es) * 2004-07-30 2007-07-11 Rinat Neuroscience Corp Anticuerpos dirigidos peptido beta-amiloide y procedimientos que usan los mismos.
ATE492561T1 (de) * 2006-03-23 2011-01-15 Bioartic Neuroscience Ab Verbesserte protofibrilselektive antikörper und deren verwendung
KR101377535B1 (ko) * 2007-11-16 2014-03-27 더 락커펠러 유니버시티 원섬유 형태의 베타­아밀로이드 단백질에 대해 특이적인 항체
PT2282758T (pt) * 2008-04-29 2019-02-12 Bioarctic Ab Anticorpos e vacinas para uso em métodos terapêuticos e diagnósticos para perturbações relacionadas com a alfa-sinucleína

Also Published As

Publication number Publication date
JP2017197531A (ja) 2017-11-02
PT2448968T (pt) 2021-04-30
AU2010267640A1 (en) 2012-01-19
ES2864049T3 (es) 2021-10-13
AU2010267640B2 (en) 2015-03-05
CY1124034T1 (el) 2022-05-27
EP3892633A1 (en) 2021-10-13
CA2765602C (en) 2021-05-25
JP6884025B2 (ja) 2021-06-09
LT2448968T (lt) 2021-05-10
WO2011001366A1 (en) 2011-01-06
EP2448968A1 (en) 2012-05-09
US20120100129A1 (en) 2012-04-26
US20230295283A1 (en) 2023-09-21
SI2448968T1 (sl) 2021-07-30
HUE053949T2 (hu) 2021-08-30
JP2019218362A (ja) 2019-12-26
JP2012532094A (ja) 2012-12-13
HRP20210611T1 (hr) 2021-05-28
PL2448968T3 (pl) 2021-09-13
SMT202100237T1 (it) 2021-05-07
EP2448968B1 (en) 2021-01-27
CA2765602A1 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
DK2448968T3 (da) ANTISTOFFER SOM ER SELEKTIVE FOR N-TERMINAL-TRUNKEREDE AMYLOID-ß PROTOFIBRILLER/OLIGOMERER
PT2406284T (pt) Anticorpos anti-bcma
BRPI1014262A2 (pt) anticorpos específicos para caderina-17
ITPD20090053U1 (it) Paradordi per banchine
ES1070076Y (es) Soporte-inmovilizador para cerramientos de vidrio
TH93312B (th) ขวด
CN301156155S (zh) 瓶(09-300)
CN301156156S (zh) 瓶(09-120)
ITMI20080090U1 (it) Contenitore -espositore per bottiglie
ES1071124Y (es) Parapente para aeromodelismo
UA20820S (uk) Упакування для яєць
UA19091S (uk) Упаковка для яєць
ES1070987Y (es) Agrupador para botellas
UA19340S (uk) Упаковка для вермішелі
TH93146B (th) ขวด
CN301360184S (zh)
UA18914S (uk) Пляшка
UA19529S (uk) Пляшка
TH104927B (th) ขวด
UA18454S (uk) Пляшка
UA18757S (uk) Пляшка
UA18825S (uk) Пляшка
UA18908S (uk) Пляшка
UA19146S (uk) Пляшка
UA19659S (uk) Пляшка